\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ 137\\/90\\ pulse\\ 112\\ resp\\ 28\\ wt\\ 11kg\\ ht\\ 80\\.6cm\\ bmi\\ 16\\.9\\ temp\\ 36\\.2\\&\\#730\\;c\\ \\ \\ \ \(0\)\
\-\ gen\\:\\ crying\\ but\\ consolable\\;\\ child\\ is\\ small\\ for\\ age\\ but\\ proportionate\\.\\ height\\ is\\ \\<\\ 5th\\ percentile\\ for\\ age\\,\\ weight\\ just\\ at\\ 5th\\ percentile\\ for\\ age\\.\\ \ \(0\)\
\-\ heent\\:\\ normal\\.\\ oropharynx\\ is\\ clear\\.\\ neck\\ supple\\ with\\ no\\ lymphadenopathy\\.\ \(0\)\
\-\ lungs\\:\\ ctab\ \(0\)\
\-\ cv\\:\\ no\\ murmurs\\,\\ rrr\ \(0\)\
\-\ abd\\:\\ distended\\ but\\ nontender\\.\\ \\+bs\\.\\ \\ palpation\\ c\\/w\\ large\\ firm\\ mass\\ filling\\ right\\ side\\ of\\ the\\ abdomen\\ and\\ extending\\ below\\ the\\ umbilicus\\.\\ lower\\ edge\\ of\\ mass\\ is\\ palpable\\ about\\ the\\ level\\ of\\ the\\ anterior\\ iliac\\ spine\\.\\ \ \(0\)\
\-\ gu\\:\\ only\\ superficial\\ visual\\ inspection\\ of\\ perineal\\ region\\.\\ normal\\ female\\ genitalia\\ with\\ no\\ labial\\ edema\\ or\\ obvious\\ rash\\.\\ \ \(0\)\
\-\ ext\\:\\ no\\ c\\/c\\/e\ \(0\)\
\-\ neuro\\:\\ cn\\ 2\\-12\\ intact\\,\\ reflexes\\ symmetric\\.\\ normal\\ gait\\.\ \(0\)\
\-\ skin\\:\\ no\\ lesions\\ or\\ rashes\\.\\ \\ \\ \ \(0\)\
\-\ soft\\ tissue\\,\\ right\\ renal\\ mass\\,\\ biopsies\\:\\ \\ tissue\\ suboptimal\\ for\\ definitive\\ evaluation\\.\\ small\\ round\\ blue\\ cell\\ neoplasm\\.\\ unable\\ to\\ evaluate\\ the\\ architecture\\ of\\ the\\ neoplasm\\.\\ immunostains\\ for\\ vimentin\\,\\ lca\\,\\ synaptophysin\\ and\\ chromogranin\\ all\\ appear\\ negative\\ while\\ keratin\\ appears\\ weakly\\ positive\\.\\ the\\ differential\\ diagnosis\\ includes\\ wilms\\ tumor\\,\\ clear\\ cell\\ sarcoma\\,\\ or\\ other\\ small\\ round\\ blue\\ cell\\ neoplasm\\,\\ although\\ the\\ negative\\ immunostains\\ would\\ seem\\ to\\ exclude\\ neuroblastoma\\,\\ lymphoma\\ and\\ ewing\\'s\\ sarcoma\\.\ \(0\)\
\-\ this\\ patient\\ was\\ initially\\ given\\ captopril\\ at\\ a\\ dose\\ of\\ 0\\.2mg\\/kg\\ bid\\ to\\ keep\\ her\\ bp\\ at\\ a\\ target\\ range\\ of\\ 100\\-110\\/70\\.\\ she\\ was\\ thought\\ to\\ have\\ tumor\\-induced\\ hypertension\\ that\\ would\\ improve\\ with\\ chemotherapy\\.\ \(0\)\
\-\ ct\\ in\\ the\\ axial\\ plane\\ demonstrates\\ a\\ heterogeneous\\ mass\\ in\\ the\\ right\\ kidney\\,\\ with\\ considerable\\ mass\\ effect\\.\\ the\\ liver\\ and\\ ivc\\ are\\ markedly\\ compressed\\ with\\ no\\ obvious\\ invasion\\.\\ initial\\ measurements\\ of\\ this\\ mass\\ were\\ 15\\.4\\ cm\\ in\\ the\\ craniocaudal\\ dimension\\,\\ 12\\.3\\ cm\\ in\\ the\\ ap\\ dimension\\,\\ and\\ 7\\.7\\ cm\\ in\\ the\\ lateral\\ dimension\\.\\ the\\ left\\ kidney\\ is\\ normal\\ with\\ no\\ evidence\\ of\\ masses\\ or\\ hydronephrosis\\.\\ \ \(0\)\
\-\ coronal\\ and\\ sagittal\\ reconstruction\\ views\\ demonstrate\\ a\\ well\\-circumscribed\\ mass\\ that\\ has\\ most\\ likely\\ infiltrated\\ the\\ right\\ renal\\ capsule\\.\\ cystic\\ regions\\ within\\ the\\ mass\\ are\\ most\\ notable\\ on\\ the\\ sagittal\\ view\\.\\ the\\ lateral\\ image\\ shows\\ medial\\ displacement\\ of\\ functioning\\ right\\ renal\\ parenchyma\\ \\(i\\.e\\.\\,\\ claw\\ sign\\)\\ with\\ contrast\\ excretion\\,\\ and\\ there\\ is\\ normal\\ excretion\\ from\\ the\\ left\\ kidney\\.\\ the\\ right\\ adrenal\\ gland\\ and\\ right\\ renal\\ vein\\ are\\ not\\ well\\ visualized\\.\\ \ \(0\)\
\-\ followup\\ ct\\ after\\ 5\\ weeks\\ of\\ preoperative\\ chemotherapy\\ shows\\ considerable\\ tumor\\ shrinkage\\ and\\ more\\ defined\\ areas\\ of\\ margination\\.\\ the\\ tumor\\ now\\ measures\\ 10\\.5\\ cm\\ in\\ the\\ craniocaudal\\ dimension\\,\\ 8\\ cm\\ in\\ the\\ ap\\ dimension\\,\\ and\\ 5\\.2\\ cm\\ in\\ the\\ lateral\\ dimension\\.\\ the\\ right\\ renal\\ vein\\ is\\ not\\ well\\ visualized\\.\ \(0\)\
\-\ sedated\\ abdominal\\ u\\/s\\ demonstrates\\ no\\ right\\ renal\\ vein\\ thrombus\\,\\ although\\ there\\ is\\ considerable\\ mass\\ effect\\ and\\ tortuosity\\ of\\ the\\ right\\ renal\\ vein\\.\\ the\\ ivc\\ is\\ clearly\\ visualized\\ with\\ no\\ evidence\\ of\\ intraluminal\\ thrombus\\.\\ flow\\ is\\ seen\\ throughout\\ the\\ lumen\\.\ \(0\)\
\-\ wilms\\â\\€\\™\\ tumor\\,\\ stage\\ i\\ \\(stage\\ iii\\ at\\ biopsy\\)\\ with\\ favorable\\ histology\ \(0\)\
\-\ wilms\\â\\€\\™\\ tumor\ \(0\)\
\-\ clear\\ cell\\ sarcoma\ \(2\)\
\-\ mesoblastic\\ nephroma\\ \ \(3\)\
\-\ nephroblastomatosis\ \(5\)\
\-\ neuroblastoma\ \(81\)\
\-\ complex\\ teratoma\ \(0\)\
\-\ cystic\\ renal\\ dysplasia\ \(5\)\
\-\ this\\ 2\\.5\\-year\\-old\\ girl\\ presented\\ to\\ her\\ pediatrician\\ in\\ italy\\ after\\ her\\ parents\\ noted\\ a\\ prominence\\ in\\ the\\ right\\ abdomen\\ after\\ bathing\\ her\\ in\\ march\\ 2004\\.\\ the\\ child\\ had\\ consistently\\ been\\ at\\ the\\ fifth\\ percentile\\ for\\ growth\\ up\\ to\\ that\\ point\\.\\ an\\ ultrasound\\ in\\ italy\\ revealed\\ a\\ 7\\ x\\ 8cm\\ abdominal\\ mass\\,\\ and\\ she\\ was\\ immediately\\ air\\-evac\\â\\€\\™d\\ to\\ wramc\\ for\\ further\\ evaluation\\ and\\ treatment\\.\ \(0\)\
\-\ wilms\\â\\€\\™\\ tumor\\ is\\ the\\ most\\ common\\ renal\\ tumor\\ of\\ childhood\\,\\ with\\ a\\ peak\\ incidence\\ at\\ 3\\-4\\ years\\ of\\ age\\.\\ it\\ is\\ thought\\ to\\ be\\ due\\ to\\ abnormal\\ proliferation\\ of\\ the\\ metanephric\\ blastema\\,\\ without\\ normal\\ differentiation\\ into\\ tubules\\ and\\ glomeruli\\.\\ wilms\\â\\€\\™\\ tumors\\ are\\ histologically\\ heterogeneous\\,\\ comprised\\ of\\ three\\ cell\\ types\\ in\\ varying\\ distributions\\:\\ blastemal\\ cells\\,\\ stromal\\ cells\\,\\ and\\ epithelial\\ cells\\.\\ while\\ each\\ of\\ these\\ components\\ is\\ variable\\ in\\ its\\ level\\ of\\ differentiation\\,\\ anaplasia\\ \\(either\\ focal\\ or\\ diffuse\\)\\ is\\ associated\\ with\\ an\\ unfavorable\\ prognosis\\.\\ nephroblastomatosis\\ is\\ characterized\\ by\\ the\\ presence\\ of\\ multiple\\ nephrogenic\\ rests\\,\\ which\\ are\\ foci\\ of\\ abnormally\\ present\\ renal\\ blastemal\\ cells\\.\\ it\\ is\\ thought\\ to\\ be\\ a\\ precursor\\ of\\ wilms\\â\\€\\™\\,\\ as\\ the\\ presence\\ of\\ intralobular\\ nephrogenic\\ rests\\ has\\ been\\ associated\\ with\\ the\\ development\\ of\\ wt\\.\ \(0\)\
\-\ grossly\\,\\ wt\\ is\\ an\\ intrarenal\\ mass\\ with\\ both\\ solid\\ and\\ cystic\\ components\\.\\ although\\ it\\ distorts\\ the\\ anatomy\\ of\\ the\\ collecting\\ ducts\\,\\ it\\ rarely\\ grows\\ into\\ the\\ renal\\ pelvis\\,\\ ureter\\,\\ or\\ bladder\\.\\ if\\ invasion\\ of\\ the\\ collecting\\ system\\ occurs\\,\\ a\\ patient\\ may\\ present\\ with\\ hematuria\\ and\\/or\\ obstruction\\.\\ the\\ tumor\\ is\\ usually\\ surrounded\\ by\\ a\\ pseudocapsule\\.\\ it\\ may\\ contain\\ areas\\ of\\ necrosis\\,\\ which\\ lead\\ to\\ hemorrhage\\ and\\ the\\ appearance\\ of\\ cystic\\ structures\\.\\ true\\ cysts\\ may\\ also\\ be\\ seen\\.\\ extension\\ of\\ the\\ tumor\\ mass\\ into\\ the\\ corresponding\\ renal\\ vein\\ is\\ seen\\ in\\ about\\ 40\\%\\ of\\ cases\\,\\ and\\ is\\ associated\\ with\\ a\\ higher\\ incidence\\ of\\ surgical\\ complications\\.\\ extension\\ into\\ the\\ ivc\\ is\\ associated\\ with\\ a\\ 40\\%\\ rate\\ of\\ surgical\\ complications\\.\\ large\\ tumors\\ that\\ involve\\ vital\\ structures\\ are\\ associated\\ with\\ a\\ higher\\ rate\\ of\\ surgical\\ complications\\,\\ most\\ notably\\ tumor\\ rupture\\ which\\ could\\ then\\ lead\\ to\\ recurrence\\.\\ they\\ are\\ considered\\ inoperable\\ without\\ preoperative\\ chemotherapy\\.\ \(0\)\
\-\ radiologically\\,\\ wt\\ may\\ be\\ confused\\ with\\ congenital\\ mesoblastic\\ nephroma\\,\\ in\\ the\\ first\\ year\\ of\\ life\\.\\ a\\ mesoblastic\\ nephroma\\ is\\ a\\ solitary\\ hamartoma\\ which\\ consists\\ of\\ immature\\ renal\\ stromal\\ cells\\.\\ it\\ lacks\\ blastemal\\ cells\\ and\\ neoplastic\\ metanephric\\ elements\\,\\ making\\ it\\ easy\\ to\\ differentiate\\ from\\ wt\\ pathologically\\.\\ however\\,\\ it\\ is\\ a\\ unilateral\\,\\ single\\,\\ solid\\ mass\\ arising\\ from\\ the\\ kidney\\ that\\ may\\ appear\\ heterogeneous\\ with\\ areas\\ of\\ necrosis\\ and\\ hemorrhage\\ on\\ ultrasound\\ and\\/or\\ ct\\.\\ unlike\\ wt\\,\\ mesoblastic\\ nephroma\\ tends\\ to\\ infiltrate\\ the\\ renal\\ parenchyma\\ and\\ does\\ not\\ form\\ a\\ pseudocapsule\\.\\ it\\ is\\ more\\ prominent\\ in\\ neonates\\,\\ with\\ a\\ peak\\ age\\ at\\ diagnosis\\ of\\ 3\\.5\\ months\\;\\ however\\,\\ isolated\\ cases\\ of\\ mesoblastic\\ nephroma\\ in\\ childhood\\ and\\ adulthood\\ have\\ been\\ documented\\.\\ radiation\\ therapy\\ and\\ chemotherapy\\ increase\\ the\\ chances\\ for\\ overall\\ morbidity\\,\\ while\\ excision\\ alone\\ results\\ in\\ cure\\.\ \(0\)\
\-\ the\\ national\\ wilms\\â\\€\\™\\ tumor\\ study\\ group\\ \\(nwtsg\\)\\ recommends\\ surgical\\ staging\\ of\\ every\\ case\\ with\\ the\\ following\\ breakdown\\:\ \(0\)\
\-\ stage\\ i\\:\\ the\\ tumor\\ is\\ isolated\\ to\\ the\\ kidney\\ and\\ has\\ been\\ excised\\ completely\\.\ \(0\)\
\-\ stage\\ ii\\:\\ the\\ tumor\\ had\\ extended\\ beyond\\ the\\ kidney\\ but\\ is\\ excised\\ completely\\.\\ capsular\\ penetration\\,\\ renal\\ vein\\ involvement\\,\\ and\\ renal\\ sinus\\ involvement\\ may\\ be\\ found\\.\\ biopsy\\ of\\ the\\ tumor\\ results\\ in\\ some\\ local\\ spill\\.\ \(0\)\
\-\ stage\\ iii\\:\\ there\\ is\\ residual\\ non\\-hematogenous\\ tumor\\ s\\/p\\ resection\\,\\ but\\ it\\ is\\ confined\\ to\\ the\\ abdomen\\.\\ the\\ resected\\ specimen\\ may\\ have\\ histologically\\ positive\\ margins\\,\\ or\\ part\\ of\\ the\\ tumor\\ has\\ infiltrated\\ the\\ abdominal\\ cavity\\.\\ lymph\\ node\\ findings\\ are\\ positive\\ and\\/or\\ peritoneal\\ implants\\ are\\ found\\.\\ \\ \\ \\ \ \(0\)\
\-\ stage\\ iv\\:\\ hematogenous\\ or\\ lymph\\ node\\ metastasis\\ has\\ occurred\\ outside\\ the\\ abdomen\\ or\\ pelvis\\.\\ \ \(0\)\
\-\ stage\\ v\\:\\ there\\ is\\ bilateral\\ renal\\ involvement\\ at\\ the\\ time\\ of\\ diagnosis\\.\\ each\\ side\\ is\\ assigned\\ a\\ stage\\ from\\ i\\ to\\ iii\\,\\ and\\ histology\\ is\\ based\\ on\\ biopsy\\ findings\\.\\ \ \(0\)\
\-\ postoperative\\ chemotherapy\\ and\\ radiotherapy\\ are\\ based\\ on\\ surgical\\ staging\\ and\\ follow\\ the\\ guidelines\\ of\\ the\\ nwtsg\\:\ \(0\)\
\-\ stage\\ i\\ with\\ favorable\\ or\\ unfavorable\\ histology\\ or\\ stage\\ ii\\ with\\ favorable\\ histology\\:\ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ postoperative\\ chemotherapy\\ with\\ vincristine\\ and\\ actinomycin\\ d\\ \\(18\\ week\\ course\\)\ \(0\)\
\-\ stage\\ ii\\ with\\ focal\\ anaplasia\\ or\\ stage\\ iii\\ with\\ favorable\\ histology\\ or\\ focal\\ anaplasia\\:\ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ abdominal\\ irradiation\\ \\(1080\\ cgy\\)\ \(0\)\
\-\ chemotherapy\\ with\\ vincristine\\,\\ actinomycin\\ d\\,\\ and\\ doxorubicin\\ \\(24\\ week\\ course\\)\ \(0\)\
\-\ stage\\ iv\\ with\\ favorable\\ histology\\ or\\ focal\\ anaplasia\\:\\ \ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ abdominal\\ irradiation\\ according\\ to\\ local\\ stage\\ \ \(0\)\
\-\ bilateral\\ pulmonary\\ irradiation\\ and\\ pcp\\ prophylaxis\\ \ \(0\)\
\-\ chemotherapy\\ with\\ vincristine\\,\\ actinomycin\\ d\\,\\ and\\ doxorubicin\\ \\(24\\ week\\ course\\)\ \(0\)\
\-\ stage\\ ii\\ through\\ stage\\ iv\\ with\\ diffuse\\ anaplasia\\:\ \(0\)\
\-\ nephrectomy\ \(68\)\
\-\ abdominal\\ irradiation\ \(0\)\
\-\ whole\\ lung\\ irradiation\\ \ \(0\)\
\-\ chemotherapy\\ with\\ vincristine\\,\\ doxorubicin\\,\\ etoposide\\,\\ and\\ cyclophosphamide\\ \\(24\\ week\\ course\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.263423773328814\ \(0\)\
\-\ stage\\:\\ 0\\.25878763878936517\ \(0\)\
\-\ renal\\:\\ 0\\.21501429356834637\ \(0\)\
\-\ tumor\\:\\ 0\\.180600364925938\ \(0\)\
\-\ of\\:\\ 0\\.1748853846403568\ \(0\)\
\-\ is\\:\\ 0\\.17242691203489469\ \(0\)\
\-\ anaplasia\\:\\ 0\\.16240426467418845\ \(0\)\
\-\ wilms\\:\\ 0\\.15602963951338003\ \(0\)\
\-\ and\\:\\ 0\\.15108871131752694\ \(0\)\
\-\ wt\\:\\ 0\\.13565408273285942\ \(0\)\
\-\ mesoblastic\\:\\ 0\\.13205537301188575\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.12979595576508576\ \(0\)\
\-\ histology\\:\\ 0\\.12934205709479926\ \(0\)\
\-\ nephroma\\:\\ 0\\.1290813815228966\ \(0\)\
\-\ dimension\\:\\ 0\\.12569697051237644\ \(0\)\
\-\ irradiation\\:\\ 0\\.12538486787658426\ \(0\)\
\-\ with\\:\\ 0\\.12328832357036824\ \(0\)\
\-\ or\\:\\ 0\\.12011602685916968\ \(0\)\
\-\ favorable\\:\\ 0\\.11606970788320367\ \(0\)\
\-\ it\\:\\ 0\\.10396642452390212\ \(0\)\
\-\ in\\:\\ 0\\.10105168382843369\ \(0\)\
\-\ mass\\:\\ 0\\.1008547138526629\ \(0\)\
\-\ vincristine\\:\\ 0\\.09577245926348082\ \(0\)\
\-\ cells\\:\\ 0\\.093893553112898\ \(0\)\
\-\ blastemal\\:\\ 0\\.09311156701933002\ \(0\)\
\-\ to\\:\\ 0\\.0913963681804863\ \(0\)\
\-\ actinomycin\\:\\ 0\\.08765516266800583\ \(0\)\
\-\ vein\\:\\ 0\\.08734976934398822\ \(0\)\
\-\ kidney\\:\\ 0\\.08561306325291912\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.08298392716053515\ \(0\)\
\-\ are\\:\\ 0\\.07706897230738091\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.07592029152330193\ \(0\)\
\-\ right\\:\\ 0\\.07407134958993779\ \(0\)\
\-\ percentile\\:\\ 0\\.07232624985705847\ \(0\)\
\-\ considerable\\:\\ 0\\.07232624985705847\ \(0\)\
\-\ may\\:\\ 0\\.07154606008549678\ \(0\)\
\-\ iii\\:\\ 0\\.07014663755231564\ \(0\)\
\-\ cm\\:\\ 0\\.06998717792936336\ \(0\)\
\-\ abdominal\\:\\ 0\\.06664998792603101\ \(0\)\
\-\ nwtsg\\:\\ 0\\.06496170586967538\ \(0\)\
\-\ ii\\:\\ 0\\.06405430204952871\ \(0\)\
\-\ age\\:\\ 0\\.06375555066773213\ \(0\)\
\-\ italy\\:\\ 0\\.06207437801288668\ \(0\)\
\-\ at\\:\\ 0\\.06137215387462815\ \(0\)\
\-\ immunostains\\:\\ 0\\.060025786296661485\ \(0\)\
\-\ course\\:\\ 0\\.06000957559491044\ \(0\)\
\-\ no\\:\\ 0\\.05944258496836206\ \(0\)\
\-\ ivc\\:\\ 0\\.05916505779606358\ \(0\)\
\-\ metanephric\\:\\ 0\\.05843677511200388\ \(0\)\
\-\ cell\\:\\ 0\\.05809260472819696\ \(0\)\
\-\ unfavorable\\:\\ 0\\.056040747334508256\ \(0\)\
\-\ pseudocapsule\\:\\ 0\\.056040747334508256\ \(0\)\
\-\ week\\:\\ 0\\.05464364066617671\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.05425113058308407\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.05425113058308407\ \(0\)\
\-\ associated\\:\\ 0\\.053525687024103985\ \(0\)\
\-\ infiltrated\\:\\ 0\\.05282214920475431\ \(0\)\
\-\ thought\\:\\ 0\\.05260997816423673\ \(0\)\
\-\ rests\\:\\ 0\\.051632552609158645\ \(0\)\
\-\ sarcoma\\:\\ 0\\.05111361411148431\ \(0\)\
\-\ her\\:\\ 0\\.05075530205202595\ \(0\)\
\-\ but\\:\\ 0\\.0502177799988239\ \(0\)\
\-\ normal\\:\\ 0\\.04975575666152652\ \(0\)\
\-\ histologically\\:\\ 0\\.04972223760059475\ \(0\)\
\-\ abdomen\\:\\ 0\\.04957107006763694\ \(0\)\
\-\ surgical\\:\\ 0\\.04935773924372879\ \(0\)\
\-\ for\\:\\ 0\\.04924756518389605\ \(0\)\
\-\ cystic\\:\\ 0\\.04892920514118148\ \(0\)\
\-\ focal\\:\\ 0\\.04859520533286061\ \(0\)\
\-\ visualized\\:\\ 0\\.04757958125495656\ \(0\)\
\-\ craniocaudal\\:\\ 0\\.04756968744404645\ \(0\)\
\-\ been\\:\\ 0\\.047332424596477046\ \(0\)\
\-\ complications\\:\\ 0\\.04666689486670186\ \(0\)\
\-\ has\\:\\ 0\\.0463861399297937\ \(0\)\
\-\ blue\\:\\ 0\\.04616890818848047\ \(0\)\
\-\ excretion\\:\\ 0\\.04616890818848047\ \(0\)\
\-\ hematogenous\\:\\ 0\\.04616890818848047\ \(0\)\
\-\ excised\\:\\ 0\\.04521802757761981\ \(0\)\
\-\ stromal\\:\\ 0\\.04437929143705629\ \(0\)\
\-\ preoperative\\:\\ 0\\.04418418261057824\ \(0\)\
\-\ clear\\:\\ 0\\.04417344703328511\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.04410078321540695\ \(0\)\
\-\ involvement\\:\\ 0\\.04410078321540695\ \(0\)\
\-\ that\\:\\ 0\\.04406989769304483\ \(0\)\
\-\ iv\\:\\ 0\\.04353661037814046\ \(0\)\
\-\ 24\\:\\ 0\\.043198558745823394\ \(0\)\
\-\ into\\:\\ 0\\.04318677128157566\ \(0\)\
\-\ biopsy\\:\\ 0\\.04271073241897512\ \(0\)\
\-\ most\\:\\ 0\\.04228072119864947\ \(0\)\
\-\ postoperative\\:\\ 0\\.042183869226327234\ \(0\)\
\-\ peak\\:\\ 0\\.041625070758344145\ \(0\)\
\-\ neoplasm\\:\\ 0\\.041594861202316404\ \(0\)\
\-\ staging\\:\\ 0\\.04149196358026758\ \(0\)\
\-\ although\\:\\ 0\\.041480923694968426\ \(0\)\
\-\ areas\\:\\ 0\\.041368188716738204\ \(0\)\
\-\ be\\:\\ 0\\.041195715619682764\ \(0\)\
\-\ childhood\\:\\ 0\\.041106949454536246\ \(0\)\
\-\ positive\\:\\ 0\\.04015065724144095\ \(0\)\
\-\ differentiation\\:\\ 0\\.03944337186404239\ \(0\)\
\-\ while\\:\\ 0\\.039378742966780414\ \(0\)\
\-\ isolated\\:\\ 0\\.038604635723478865\ \(0\)\
\-\ each\\:\\ 0\\.03851726006664116\ \(0\)\
\-\ collecting\\:\\ 0\\.03809577453370698\ \(0\)\
\-\ 5th\\:\\ 0\\.03777567450097762\ \(0\)\
\-\ obvious\\:\\ 0\\.03777567450097762\ \(0\)\
\-\ thrombus\\:\\ 0\\.03777567450097762\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.03732098646475208\ \(0\)\
\-\ which\\:\\ 0\\.0369414795569344\ \(0\)\
\-\ components\\:\\ 0\\.036893596615597914\ \(0\)\
\-\ higher\\:\\ 0\\.036893596615597914\ \(0\)\
\-\ completely\\:\\ 0\\.03629706904245268\ \(0\)\
\-\ invasion\\:\\ 0\\.036233770610646567\ \(0\)\
\-\ lead\\:\\ 0\\.03617102988152235\ \(0\)\
\-\ incidence\\:\\ 0\\.03496703282259608\ \(0\)\
\-\ local\\:\\ 0\\.03496703282259608\ \(0\)\
\-\ node\\:\\ 0\\.034914478881553065\ \(0\)\
\-\ child\\:\\ 0\\.03362489430946184\ \(0\)\
\-\ round\\:\\ 0\\.03328370202473364\ \(0\)\
\-\ parenchyma\\:\\ 0\\.03299800647814792\ \(0\)\
\-\ bp\\:\\ 0\\.03295811266686045\ \(0\)\
\-\ 11kg\\:\\ 0\\.03248085293483769\ \(0\)\
\-\ 730\\:\\ 0\\.03248085293483769\ \(0\)\
\-\ proportionate\\:\\ 0\\.03248085293483769\ \(0\)\
\-\ chromogranin\\:\\ 0\\.03248085293483769\ \(0\)\
\-\ 1080\\:\\ 0\\.03248085293483769\ \(0\)\
\-\ there\\:\\ 0\\.03232588177151611\ \(0\)\
\-\ from\\:\\ 0\\.0322658203082036\ \(0\)\
\-\ appear\\:\\ 0\\.03199232930896966\ \(0\)\
\-\ results\\:\\ 0\\.031653168700914364\ \(0\)\
\-\ lymph\\:\\ 0\\.03158723279751646\ \(0\)\
\-\ diagnosis\\:\\ 0\\.031586401160058064\ \(0\)\
\-\ small\\:\\ 0\\.0314304634995734\ \(0\)\
\-\ sagittal\\:\\ 0\\.031235110308508455\ \(0\)\
\-\ solid\\:\\ 0\\.03114202366677068\ \(0\)\
\-\ necrosis\\:\\ 0\\.03105013817653955\ \(0\)\
\-\ labial\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ vimentin\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ lca\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ synaptophysin\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ margination\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ glomeruli\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ distorts\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ chances\\:\\ 0\\.03103718900644334\ \(0\)\
\-\ rate\\:\\ 0\\.03078138829367627\ \(0\)\
\-\ structures\\:\\ 0\\.030522413328875266\ \(0\)\
\-\ have\\:\\ 0\\.030438571922446447\ \(0\)\
\-\ about\\:\\ 0\\.030410268858578133\ \(0\)\
\-\ lateral\\:\\ 0\\.030238911155331595\ \(0\)\
\-\ shrinkage\\:\\ 0\\.030012893148330742\ \(0\)\
\-\ blastema\\:\\ 0\\.030012893148330742\ \(0\)\
\-\ inoperable\\:\\ 0\\.030012893148330742\ \(0\)\
\-\ tumors\\:\\ 0\\.029874600868216063\ \(0\)\
\-\ 40\\:\\ 0\\.029874600868216063\ \(0\)\
\-\ after\\:\\ 0\\.029558816554859632\ \(0\)\
\-\ well\\:\\ 0\\.029503279826446783\ \(0\)\
\-\ based\\:\\ 0\\.029424702223510735\ \(0\)\
\-\ consolable\\:\\ 0\\.02921838755600194\ \(0\)\
\-\ weakly\\:\\ 0\\.02921838755600194\ \(0\)\
\-\ assigned\\:\\ 0\\.02921838755600194\ \(0\)\
\-\ presence\\:\\ 0\\.029186518592283273\ \(0\)\
\-\ ap\\:\\ 0\\.02916313260512293\ \(0\)\
\-\ would\\:\\ 0\\.028754809042244315\ \(0\)\
\-\ extension\\:\\ 0\\.028754809042244315\ \(0\)\
\-\ seen\\:\\ 0\\.028686005472345864\ \(0\)\
\-\ keratin\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ bathing\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ consistently\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ comprised\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ intralobular\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ radiologically\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ cgy\\:\\ 0\\.02856922921993639\ \(0\)\
\-\ effect\\:\\ 0\\.02849504674517536\ \(0\)\
\-\ pelvis\\:\\ 0\\.02841052318084396\ \(0\)\
\-\ side\\:\\ 0\\.02806208690513403\ \(0\)\
\-\ captopril\\:\\ 0\\.028020373667254128\ \(0\)\
\-\ recommends\\:\\ 0\\.028020373667254128\ \(0\)\
\-\ spill\\:\\ 0\\.028020373667254128\ \(0\)\
\-\ precursor\\:\\ 0\\.027544933361823797\ \(0\)\
\-\ cases\\:\\ 0\\.027321820333088356\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.02719673007304426\ \(0\)\
\-\ crying\\:\\ 0\\.027125565291542034\ \(0\)\
\-\ distributions\\:\\ 0\\.027125565291542034\ \(0\)\
\-\ etoposide\\:\\ 0\\.027125565291542034\ \(0\)\
\-\ 112\\:\\ 0\\.026750427769494996\ \(0\)\
\-\ sedated\\:\\ 0\\.026750427769494996\ \(0\)\
\-\ tubules\\:\\ 0\\.026411074602377155\ \(0\)\
\-\ easy\\:\\ 0\\.026411074602377155\ \(0\)\
\-\ found\\:\\ 0\\.026283591547021787\ \(0\)\
\-\ perineal\\:\\ 0\\.02610126943342944\ \(0\)\
\-\ suboptimal\\:\\ 0\\.02610126943342944\ \(0\)\
\-\ claw\\:\\ 0\\.02610126943342944\ \(0\)\
\-\ wramc\\:\\ 0\\.02610126943342944\ \(0\)\
\-\ intrarenal\\:\\ 0\\.02610126943342944\ \(0\)\
\-\ neonates\\:\\ 0\\.02610126943342944\ \(0\)\
\-\ tortuosity\\:\\ 0\\.025816276304579323\ \(0\)\
\-\ grows\\:\\ 0\\.025816276304579323\ \(0\)\
\-\ cure\\:\\ 0\\.025816276304579323\ \(0\)\
\-\ umbilicus\\:\\ 0\\.02555241388074718\ \(0\)\
\-\ bid\\:\\ 0\\.02555241388074718\ \(0\)\
\-\ diffuse\\:\\ 0\\.025474349285564236\ \(0\)\
\-\ breakdown\\:\\ 0\\.02530676384110064\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.02530676384110064\ \(0\)\
\-\ negative\\:\\ 0\\.02514813835681907\ \(0\)\
\-\ seem\\:\\ 0\\.025076973575316852\ \(0\)\
\-\ keep\\:\\ 0\\.025076973575316852\ \(0\)\
\-\ ultrasound\\:\\ 0\\.025055741904244935\ \(0\)\
\-\ notably\\:\\ 0\\.024861118800297375\ \(0\)\
\-\ lacks\\:\\ 0\\.024861118800297375\ \(0\)\
\-\ national\\:\\ 0\\.024861118800297375\ \(0\)\
\-\ evaluation\\:\\ 0\\.02477292027996117\ \(0\)\
\-\ pediatrician\\:\\ 0\\.02465760550503509\ \(0\)\
\-\ guidelines\\:\\ 0\\.02465760550503509\ \(0\)\
\-\ level\\:\\ 0\\.024537390529949632\ \(0\)\
\-\ on\\:\\ 0\\.024536434551326692\ \(0\)\
\-\ genitalia\\:\\ 0\\.02446509844216942\ \(0\)\
\-\ rashes\\:\\ 0\\.024282467982988047\ \(0\)\
\-\ architecture\\:\\ 0\\.024282467982988047\ \(0\)\
\-\ she\\:\\ 0\\.02418067020831552\ \(0\)\
\-\ not\\:\\ 0\\.02405426370992196\ \(0\)\
\-\ however\\:\\ 0\\.024042839582446605\ \(0\)\
\-\ immature\\:\\ 0\\.023943114815870206\ \(0\)\
\-\ implants\\:\\ 0\\.023943114815870206\ \(0\)\
\-\ shows\\:\\ 0\\.023840970189837645\ \(0\)\
\-\ ht\\:\\ 0\\.023784843722023226\ \(0\)\
\-\ 8cm\\:\\ 0\\.023784843722023226\ \(0\)\
\-\ adulthood\\:\\ 0\\.023784843722023226\ \(0\)\
\-\ capsular\\:\\ 0\\.023784843722023226\ \(0\)\
\-\ bmi\\:\\ 0\\.023633309646922496\ \(0\)\
\-\ measurements\\:\\ 0\\.023633309646922496\ \(0\)\
\-\ pathologically\\:\\ 0\\.023633309646922496\ \(0\)\
\-\ tends\\:\\ 0\\.023487962390659246\ \(0\)\
\-\ penetration\\:\\ 0\\.023487962390659246\ \(0\)\
\-\ resp\\:\\ 0\\.023348316518072374\ \(0\)\
\-\ gu\\:\\ 0\\.023348316518072374\ \(0\)\
\-\ inspection\\:\\ 0\\.023348316518072374\ \(0\)\
\-\ an\\:\\ 0\\.023299959338529155\ \(0\)\
\-\ ct\\:\\ 0\\.02319715257729404\ \(0\)\
\-\ biopsies\\:\\ 0\\.023084454094240234\ \(0\)\
\-\ march\\:\\ 0\\.023084454094240234\ \(0\)\
\-\ evidence\\:\\ 0\\.02305649914983097\ \(0\)\
\-\ pcp\\:\\ 0\\.022722055452848743\ \(0\)\
\-\ unlike\\:\\ 0\\.022609013788809904\ \(0\)\
\-\ functioning\\:\\ 0\\.02249945088747585\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.022393159013790426\ \(0\)\
\-\ more\\:\\ 0\\.022305233767554326\ \(0\)\
\-\ ctab\\:\\ 0\\.022289948501911433\ \(0\)\
\-\ oropharynx\\:\\ 0\\.022189645718528144\ \(0\)\
\-\ supple\\:\\ 0\\.022189645718528144\ \(0\)\
\-\ compressed\\:\\ 0\\.021997138655662475\ \(0\)\
\-\ radiotherapy\\:\\ 0\\.021997138655662475\ \(0\)\
\-\ rash\\:\\ 0\\.02190465258967802\ \(0\)\
\-\ ewing\\:\\ 0\\.02190465258967802\ \(0\)\
\-\ bilateral\\:\\ 0\\.021831185254613403\ \(0\)\
\-\ proliferation\\:\\ 0\\.021814508196481102\ \(0\)\
\-\ epithelial\\:\\ 0\\.021814508196481102\ \(0\)\
\-\ morbidity\\:\\ 0\\.021814508196481102\ \(0\)\
\-\ ext\\:\\ 0\\.02172658981982753\ \(0\)\
\-\ documented\\:\\ 0\\.02172658981982753\ \(0\)\
\-\ confined\\:\\ 0\\.02172658981982753\ \(0\)\
\-\ specimen\\:\\ 0\\.02164079016584588\ \(0\)\
\-\ infiltrate\\:\\ 0\\.021557009515799877\ \(0\)\
\-\ prominence\\:\\ 0\\.02147515502936326\ \(0\)\
\-\ confused\\:\\ 0\\.02147515502936326\ \(0\)\
\-\ without\\:\\ 0\\.021426011891604882\ \(0\)\
\-\ differentiate\\:\\ 0\\.02139514012619934\ \(0\)\
\-\ varying\\:\\ 0\\.02131688393551628\ \(0\)\
\-\ whole\\:\\ 0\\.02131688393551628\ \(0\)\
\-\ tissue\\:\\ 0\\.02130882285042823\ \(0\)\
\-\ was\\:\\ 0\\.021235192967460074\ \(0\)\
\-\ parents\\:\\ 0\\.021165349860415548\ \(0\)\
\-\ beyond\\:\\ 0\\.021165349860415548\ \(0\)\
\-\ reconstruction\\:\\ 0\\.021091934613163617\ \(0\)\
\-\ target\\:\\ 0\\.021020002604152297\ \(0\)\
\-\ ducts\\:\\ 0\\.02094949508539607\ \(0\)\
\-\ extended\\:\\ 0\\.02094949508539607\ \(0\)\
\-\ this\\:\\ 0\\.020937123187625962\ \(0\)\
\-\ surrounded\\:\\ 0\\.02088035673156543\ \(0\)\
\-\ present\\:\\ 0\\.02084391710065182\ \(0\)\
\-\ intraluminal\\:\\ 0\\.02074598179013379\ \(0\)\
\-\ edge\\:\\ 0\\.020491551195247842\ \(0\)\
\-\ plane\\:\\ 0\\.020491551195247842\ \(0\)\
\-\ according\\:\\ 0\\.020430686237145015\ \(0\)\
\-\ demonstrates\\:\\ 0\\.020407512133473322\ \(0\)\
\-\ large\\:\\ 0\\.020353100967581375\ \(0\)\
\-\ notable\\:\\ 0\\.02031199146790416\ \(0\)\
\-\ contain\\:\\ 0\\.02031199146790416\ \(0\)\
\-\ making\\:\\ 0\\.02031199146790416\ \(0\)\
\-\ had\\:\\ 0\\.02023883947533143\ \(0\)\
\-\ cv\\:\\ 0\\.020197126237451523\ \(0\)\
\-\ fifth\\:\\ 0\\.020197126237451523\ \(0\)\
\-\ abnormally\\:\\ 0\\.020197126237451523\ \(0\)\
\-\ consists\\:\\ 0\\.020197126237451523\ \(0\)\
\-\ temp\\:\\ 0\\.02014105400230296\ \(0\)\
\-\ elements\\:\\ 0\\.02014105400230296\ \(0\)\
\-\ findings\\:\\ 0\\.02004805691064515\ \(0\)\
\-\ gen\\:\\ 0\\.020031491100968905\ \(0\)\
\-\ hamartoma\\:\\ 0\\.019977948537930376\ \(0\)\
\-\ alone\\:\\ 0\\.019977948537930376\ \(0\)\
\-\ ureter\\:\\ 0\\.019925199227283478\ \(0\)\
\-\ capsule\\:\\ 0\\.019873220007121925\ \(0\)\
\-\ cn\\:\\ 0\\.019821988715404484\ \(0\)\
\-\ improve\\:\\ 0\\.019721685932021196\ \(0\)\
\-\ variable\\:\\ 0\\.019721685932021196\ \(0\)\
\-\ true\\:\\ 0\\.019721685932021196\ \(0\)\
\-\ every\\:\\ 0\\.019672574624495655\ \(0\)\
\-\ superficial\\:\\ 0\\.019624131518782173\ \(0\)\
\-\ exclude\\:\\ 0\\.019624131518782173\ \(0\)\
\-\ occurred\\:\\ 0\\.019624131518782173\ \(0\)\
\-\ height\\:\\ 0\\.019482635548286643\ \(0\)\
\-\ murmurs\\:\\ 0\\.019482635548286643\ \(0\)\
\-\ grossly\\:\\ 0\\.019482635548286643\ \(0\)\
\-\ group\\:\\ 0\\.019302317861739433\ \(0\)\
\-\ anatomy\\:\\ 0\\.01925863003332058\ \(0\)\
\-\ pulse\\:\\ 0\\.01917283037933893\ \(0\)\
\-\ nontender\\:\\ 0\\.019130693634954676\ \(0\)\
\-\ clearly\\:\\ 0\\.019130693634954676\ \(0\)\
\-\ peritoneal\\:\\ 0\\.019089049729292932\ \(0\)\
\-\ corresponding\\:\\ 0\\.019007195242856312\ \(0\)\
\-\ dose\\:\\ 0\\.01896696302558091\ \(0\)\
\-\ rrr\\:\\ 0\\.018927180339692394\ \(0\)\
\-\ neuro\\:\\ 0\\.018927180339692394\ \(0\)\
\-\ abd\\:\\ 0\\.01888783725048881\ \(0\)\
\-\ types\\:\\ 0\\.01888783725048881\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.018848924149009332\ \(0\)\
\-\ adrenal\\:\\ 0\\.01881043173794744\ \(0\)\
\-\ neoplastic\\:\\ 0\\.018772351018317483\ \(0\)\
\-\ iliac\\:\\ 0\\.018697390073908606\ \(0\)\
\-\ characterized\\:\\ 0\\.01866049323237604\ \(0\)\
\-\ overall\\:\\ 0\\.01866049323237604\ \(0\)\
\-\ immediately\\:\\ 0\\.01858782717257455\ \(0\)\
\-\ solitary\\:\\ 0\\.01858782717257455\ \(0\)\
\-\ unilateral\\:\\ 0\\.01858782717257455\ \(0\)\
\-\ resected\\:\\ 0\\.01858782717257455\ \(0\)\
\-\ definitive\\:\\ 0\\.018552042817645352\ \(0\)\
\-\ residual\\:\\ 0\\.018481535298889126\ \(0\)\
\-\ firm\\:\\ 0\\.01841239694505848\ \(0\)\
\-\ heent\\:\\ 0\\.01814853452122634\ \(0\)\
\-\ part\\:\\ 0\\.01814853452122634\ \(0\)\
\-\ rarely\\:\\ 0\\.018116885305323283\ \(0\)\
\-\ lumen\\:\\ 0\\.018085514940761174\ \(0\)\
\-\ vital\\:\\ 0\\.018085514940761174\ \(0\)\
\-\ hematuria\\:\\ 0\\.017962726450638067\ \(0\)\
\-\ markedly\\:\\ 0\\.017932679746206864\ \(0\)\
\-\ followup\\:\\ 0\\.017932679746206864\ \(0\)\
\-\ prognosis\\:\\ 0\\.017873336483409667\ \(0\)\
\-\ involve\\:\\ 0\\.017873336483409667\ \(0\)\
\-\ reflexes\\:\\ 0\\.01775753722531655\ \(0\)\
\-\ form\\:\\ 0\\.01775753722531655\ \(0\)\
\-\ gait\\:\\ 0\\.017590607592057224\ \(0\)\
\-\ unable\\:\\ 0\\.017590607592057224\ \(0\)\
\-\ teratoma\\:\\ 0\\.017563531314461957\ \(0\)\
\-\ regions\\:\\ 0\\.017431154977261918\ \(0\)\
\-\ symmetric\\:\\ 0\\.01740526022061498\ \(0\)\
\-\ distended\\:\\ 0\\.017354028928897536\ \(0\)\
\-\ visual\\:\\ 0\\.01732868708992313\ \(0\)\
\-\ margins\\:\\ 0\\.01732868708992313\ \(0\)\
\-\ by\\:\\ 0\\.017250001617102467\ \(0\)\
\-\ 28\\:\\ 0\\.016856404667932715\ \(0\)\
\-\ point\\:\\ 0\\.016790670246813633\ \(0\)\
\-\ either\\:\\ 0\\.016790670246813633\ \(0\)\
\-\ development\\:\\ 0\\.016790670246813633\ \(0\)\
\-\ recurrence\\:\\ 0\\.01676902572213316\ \(0\)\
\-\ cavity\\:\\ 0\\.01676902572213316\ \(0\)\
\-\ growth\\:\\ 0\\.01674751198087737\ \(0\)\
\-\ below\\:\\ 0\\.01672612745205995\ \(0\)\
\-\ life\\:\\ 0\\.01666273384844773\ \(0\)\
\-\ foci\\:\\ 0\\.016600449227907786\ \(0\)\
\-\ displacement\\:\\ 0\\.016559523336568734\ \(0\)\
\-\ measures\\:\\ 0\\.016559523336568734\ \(0\)\
\-\ gland\\:\\ 0\\.01649900323907396\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.016419877463981863\ \(0\)\
\-\ rupture\\:\\ 0\\.016419877463981863\ \(0\)\
\-\ increase\\:\\ 0\\.016304391231810537\ \(0\)\
\-\ outside\\:\\ 0\\.016304391231810537\ \(0\)\
\-\ just\\:\\ 0\\.016248023088633948\ \(0\)\
\-\ coronal\\:\\ 0\\.016174227424335323\ \(0\)\
\-\ arising\\:\\ 0\\.016137895340254196\ \(0\)\
\-\ views\\:\\ 0\\.016031071927664283\ \(0\)\
\-\ occurs\\:\\ 0\\.016013575512382177\ \(0\)\
\-\ excision\\:\\ 0\\.016013575512382177\ \(0\)\
\-\ prominent\\:\\ 0\\.01599616465448483\ \(0\)\
\-\ initially\\:\\ 0\\.015927360323201935\ \(0\)\
\-\ considered\\:\\ 0\\.015826584350457182\ \(0\)\
\-\ evaluate\\:\\ 0\\.01579361639875823\ \(0\)\
\-\ includes\\:\\ 0\\.01579361639875823\ \(0\)\
\-\ range\\:\\ 0\\.015760950909594354\ \(0\)\
\-\ bladder\\:\\ 0\\.015760950909594354\ \(0\)\
\-\ filling\\:\\ 0\\.015728582383532055\ \(0\)\
\-\ complex\\:\\ 0\\.015648925518816335\ \(0\)\
\-\ single\\:\\ 0\\.015617555154254227\ \(0\)\
\-\ dysplasia\\:\\ 0\\.015555631622233952\ \(0\)\
\-\ hypertension\\:\\ 0\\.015540317562732772\ \(0\)\
\-\ system\\:\\ 0\\.01549476666413112\ \(0\)\
\-\ cysts\\:\\ 0\\.015390694146838135\ \(0\)\
\-\ 18\\:\\ 0\\.015390694146838135\ \(0\)\
\-\ skin\\:\\ 0\\.015109083928784168\ \(0\)\
\-\ its\\:\\ 0\\.015028768192250538\ \(0\)\
\-\ lungs\\:\\ 0\\.014989279654269586\ \(0\)\
\-\ throughout\\:\\ 0\\.014937300434108031\ \(0\)\
\-\ metastasis\\:\\ 0\\.01488606914239059\ \(0\)\
\-\ appears\\:\\ 0\\.014873375676735712\ \(0\)\
\-\ view\\:\\ 0\\.014873375676735712\ \(0\)\
\-\ could\\:\\ 0\\.014773424879250104\ \(0\)\
\-\ intact\\:\\ 0\\.014700261071802318\ \(0\)\
\-\ sinus\\:\\ 0\\.014676203457673247\ \(0\)\
\-\ congenital\\:\\ 0\\.014593259296141636\ \(0\)\
\-\ they\\:\\ 0\\.014512203459380153\ \(0\)\
\-\ defined\\:\\ 0\\.014489379577730247\ \(0\)\
\-\ then\\:\\ 0\\.014377404521122157\ \(0\)\
\-\ palpable\\:\\ 0\\.014268843875486518\ \(0\)\
\-\ girl\\:\\ 0\\.01424752337258768\ \(0\)\
\-\ obstruction\\:\\ 0\\.014226329778195851\ \(0\)\
\-\ weight\\:\\ 0\\.014163495559073105\ \(0\)\
\-\ sign\\:\\ 0\\.014061174915989957\ \(0\)\
\-\ does\\:\\ 0\\.014041058967877457\ \(0\)\
\-\ liver\\:\\ 0\\.014011096546923276\ \(0\)\
\-\ given\\:\\ 0\\.013971534880516822\ \(0\)\
\-\ now\\:\\ 0\\.013942149459152958\ \(0\)\
\-\ left\\:\\ 0\\.013856684226556294\ \(0\)\
\-\ masses\\:\\ 0\\.013826974564989476\ \(0\)\
\-\ extending\\:\\ 0\\.013770754765203834\ \(0\)\
\-\ first\\:\\ 0\\.013706267637828378\ \(0\)\
\-\ palpation\\:\\ 0\\.01369714980097596\ \(0\)\
\-\ three\\:\\ 0\\.013633970466687094\ \(0\)\
\-\ initial\\:\\ 0\\.01362503567317761\ \(0\)\
\-\ study\\:\\ 0\\.013545615725875232\ \(0\)\
\-\ flow\\:\\ 0\\.013528204867977884\ \(0\)\
\-\ radiation\\:\\ 0\\.013459400536694989\ \(0\)\
\-\ spine\\:\\ 0\\.013417063375021828\ \(0\)\
\-\ revealed\\:\\ 0\\.013317462101510793\ \(0\)\
\-\ further\\:\\ 0\\.013228545683268315\ \(0\)\
\-\ medial\\:\\ 0\\.01322057140592587\ \(0\)\
\-\ patient\\:\\ 0\\.0132119484167799\ \(0\)\
\-\ differential\\:\\ 0\\.013196755174349695\ \(0\)\
\-\ resection\\:\\ 0\\.013019271396832392\ \(0\)\
\-\ image\\:\\ 0\\.01298928794936947\ \(0\)\
\-\ usually\\:\\ 0\\.012786189366511722\ \(0\)\
\-\ some\\:\\ 0\\.012779145816548794\ \(0\)\
\-\ only\\:\\ 0\\.012688825513006487\ \(0\)\
\-\ year\\:\\ 0\\.012518570019825766\ \(0\)\
\-\ years\\:\\ 0\\.012450042425045122\ \(0\)\
\-\ neck\\:\\ 0\\.012424473099034562\ \(0\)\
\-\ pulmonary\\:\\ 0\\.012380163916686273\ \(0\)\
\-\ lung\\:\\ 0\\.012355089775418477\ \(0\)\
\-\ appearance\\:\\ 0\\.012244391325248422\ \(0\)\
\-\ abnormal\\:\\ 0\\.012202254580864165\ \(0\)\
\-\ following\\:\\ 0\\.012184347518750964\ \(0\)\
\-\ weeks\\:\\ 0\\.012172459316237104\ \(0\)\
\-\ region\\:\\ 0\\.012148801333215152\ \(0\)\
\-\ likely\\:\\ 0\\.01213703103044617\ \(0\)\
\-\ edema\\:\\ 0\\.012113606516054516\ \(0\)\
\-\ lymphoma\\:\\ 0\\.012096138713177199\ \(0\)\
\-\ all\\:\\ 0\\.01209033510415776\ \(0\)\
\-\ through\\:\\ 0\\.01209033510415776\ \(0\)\
\-\ time\\:\\ 0\\.0120385239714904\ \(0\)\
\-\ presented\\:\\ 0\\.011843911964226973\ \(0\)\
\-\ months\\:\\ 0\\.011822333029417362\ \(0\)\
\-\ if\\:\\ 0\\.011800884088979571\ \(0\)\
\-\ axial\\:\\ 0\\.01173205417828553\ \(0\)\
\-\ due\\:\\ 0\\.011674835055272283\ \(0\)\
\-\ therapy\\:\\ 0\\.011669678626644602\ \(0\)\
\-\ lesions\\:\\ 0\\.011664529654893892\ \(0\)\
\-\ common\\:\\ 0\\.011518359253708445\ \(0\)\
\-\ these\\:\\ 0\\.011469315594752613\ \(0\)\
\-\ anterior\\:\\ 0\\.011340176039585995\ \(0\)\
\-\ both\\:\\ 0\\.011326112110786326\ \(0\)\
\-\ follow\\:\\ 0\\.010949103588514881\ \(0\)\
\-\ soft\\:\\ 0\\.010812858629527067\ \(0\)\
\-\ noted\\:\\ 0\\.010768578073731265\ \(0\)\
\-\ demonstrate\\:\\ 0\\.010558847091117226\ \(0\)\
\-\ other\\:\\ 0\\.010547549842046202\ \(0\)\
\-\ were\\:\\ 0\\.010469457123888826\ \(0\)\
\-\ lower\\:\\ 0\\.01037866910102301\ \(0\)\
\-\ case\\:\\ 0\\.010203756066736661\ \(0\)\
\-\ up\\:\\ 0\\.010046821028278868\ \(0\)\
\-\ multiple\\:\\ 0\\.009934289795513947\ \(0\)\
\-\ contrast\\:\\ 0\\.0098684395872257\ \(0\)\
\-\ female\\:\\ 0\\.00980073547846787\ \(0\)\
\-\ treatment\\:\\ 0\\.009674951531560025\ \(0\)\
\-\ also\\:\\ 0\\.009553460004716356\ \(0\)\
\-\ within\\:\\ 0\\.009354373242910417\ \(0\)\
\-\ as\\:\\ 0\\.0081594340636327\ \(0\)\
